NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I'm not sure I get y our point hankmanhub. The bottom 30% did not show a negative reaction to the addition of this treatment. I would expect if there were safety issues, you would have to focus on those patients.

Additionally, Adam seems to think it's all personalized now. So of course you'd then focus on what it was in those patients that responded, that made the vaccine effective, by itself. Of course, later, one might come back and look at the other patients, with combination therapy, and also see if that improves their response rate. One would never entirely dismiss them in the long-haul. But this is about getting the help to where it's needed as fast as possible, which also will be good for investors, but is particularly important for patients and is least costly (lowest hanging fruit) - and most revealing, in terms of discovering the potential, reasonable response reasons and rates for those patients most responsive.

Lastly, Adam ignored the Wheeler result/method and seemed, to be kind, not to have either paid attention to it or possibly not understood it at all, given his failure to address it.

My view on Adam is that he is obsessed with validating his outdated, market theory, for every tiny stock, and he grabs for straws at any opportunity to prove that tiny biotechs cannot succeed. His one-sided approach suggests an incredibly blind bias that makes him ineffective as a commentator and observer. He is certainly less insightful than your average bulletin board poster, in my view, and seems to intentionally look the other way, in at least 3/4ths of his articles. He never takes responsibility for the misses, by the way. Of course, those are years later, so why would he?